Tissue factor pathway inhibitor: Difference between revisions
No edit summary |
Michal Harel (talk | contribs) No edit summary |
||
| (One intermediate revision by the same user not shown) | |||
| Line 18: | Line 18: | ||
[[1irh]] – hTFPI-1 kunitz domain III - NMR<br /> | [[1irh]] – hTFPI-1 kunitz domain III - NMR<br /> | ||
[[1tfx]] – hTFPI-1 kunitz domain II + trypsin <br /> | [[1tfx]] – hTFPI-1 kunitz domain II + trypsin <br /> | ||
[[6bx8]] – hTFPI-1 kunitz domain I (mutant) + trypsin <br /> | |||
[[1zr0]] – hTFPI-2 kunitz domain I + trypsin <br /> | [[1zr0]] – hTFPI-2 kunitz domain I + trypsin <br /> | ||
[[5nmv]] – hTFPI-1 kunitz domain I + antibody <br /> | [[5nmv]] – hTFPI-1 kunitz domain I + antibody <br /> | ||
[[4dtg]] – hTFPI-1 kunitz domain II + antibody <br /> | [[4dtg]] – hTFPI-1 kunitz domain II + antibody <br /> | ||
[[4bqd]] – hTFPI-1 kunitz domain I + peptide <br /> | [[4bqd]] – hTFPI-1 kunitz domain I + peptide <br /> | ||
[[7v1n]] – hTFPI-1 + toxin B <br /> | |||
== References == | == References == | ||
<references/> | <references/> | ||
[[Category:Topic Page]] | [[Category:Topic Page]] | ||